Institutional investors purchased a net $3.1 million shares of IMMU during the quarter ended June 2016, and now own 54.45% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 60.0 Thousand shares of Immunomedics Inc